HS
Harsh Shah, DO
HCI
Faculty
Biography
Dr. Shah is an assistant professor in lymphoma division at HCI since 2019. His practice includes NHL, HL, and CLL. His research focuses on real-world outcomes of lymphoma patients, racial disparity and development of novel targeted agents for refractory lymphoma patients. He is a recipient of LSRMP award for a clinical trial which focuses on improving outcomes of patients with progression on anti-PD-1 agents with utilization of novel agents.
Financial Disclosure
Nurix, Newave, Incyte, Ipsen
Researcher
ADCT, Pfizer
Consultant